Sector to Reach $6.27 Billion by 2028 at a 9.1% CAGR

DUBLIN, Jan. 22, 2023 /PRNewswire/ — The “Global Viscosupplementation Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis” report has been added to ResearchAndMarkets.com’s providing.

Research and Markets Logo

Global Viscosupplementation Market is predicted to attain US$ 6.27 Billion by 2028 in accordance to the writer. Patients with osteoarthritis have a minimally invasive therapeutic choice known as viscosupplementation.

During viscosupplementation, hyaluronic acid is pushed into the joints. The synovial fluid that covers joints incorporates hyaluronic acid, a substance that happens naturally. It lubricates joints to enable bones to transfer freely and reduce discomfort. Hyaluronic acid ranges within the joints are decrease in these with osteoarthritis, which causes ache.

According to the analysis findings, Worldwide Viscosupplementation market was US$ 3.71 Billion in 2022.

Global Viscosupplementation Market will develop with 9.14% CAGR in the course of the forecast interval:

The enhance within the incidence of osteoarthritis, the rise within the geriatric inhabitants, and the hike within the variety of product launches and product approvals are the principle components driving the expansion of the worldwide viscosupplementation market measurement. One of probably the most prevalent sorts of arthritis is osteoarthritis.

In 2019, the Centers for Disease Control and Prevention estimated that 32.5 million Americans (1 in 7 adults) had osteoarthritis. Due to a rise in continual illnesses like weight problems, diabetes, and coronary heart illness, the prevalence of osteoarthritis has reached alarming ranges. Additionally, a lack of bodily exercise, equivalent to train, will increase the requirement for osteoarthritis remedy for the knee and hip and propels market enlargement.

Single Injection Viscosupplementation holds the lion’s share

By process, the Viscosupplementation market is split into three segments, i.e., Single Injection Viscosupplementation, Three Injection Viscosupplementation, and Five Injections Viscosupplementation. Among all, Single Injection dominates the present viscosupplementation market. The demand for outpatient surgical procedures that provide same-day surgical care, together with preventive (surgical) and diagnostic procedures, is driving the Single Injections Segment. Furthermore, a rise in product launches and give attention to growing single injections for the remedy of osteoarthritis are anticipated to contribute to the numerous development of the single-injection market over the forecast interval.

By Application: The Knee Osteoarthritis Segment dominates the Market Share

Due to the elevated prevalence of knee osteoarthritis and the rising geriatric inhabitants, who’re extra weak to knee osteoarthritis, the knee osteoarthritis phase dominated the Viscosupplementation market and is anticipated to preserve this development over the projected interval. In addition, the ageing impact, which reduces the quantity of water in cartilage and additional reduces its capability to soak up shock and cushion, makes the aged inhabitants extra vulnerable to growing knee osteoarthritis.

Orthopedic clinics/Ambulatory Surgical Centers Segment is rising at a Significant Growth Rate

By End customers, the Viscosupplementation market is segmented into Hospitals and Orthopedic clinics/Ambulatory Surgical Centers. Outpatient service websites, notably people who present ambulatory surgical procedure and doctor office-based therapies, have grown into fierce opponents for hospitals due to the latest adoption of value-based care. Orthopedic clinics/Ambulatory Surgical Centers supply each sensible and monetary advantages, equivalent to faster affected person entry, extra inexpensive costs, extra alternatives for doctor involvement, and outpatient amenities. Hence they purchase a dominant market share within the Viscosupplementation market.

By Region: North America and Asia Pacific holds a Significant Market Share

North America occupies a dominant place within the world viscosupplementation market. The components contributing to the expansion of viscosupplementation within the North American area are the elevated prevalence of osteoarthritis and associated illnesses, the ageing inhabitants, the well-established healthcare system, and the rising need for non-surgical procedures. Furthermore, Asia Pacific is predicted to develop with a notable development fee in the course of the forecast interval due to the rise within the geriatric inhabitants and rising healthcare expenditures.

Market Segmentation

Product

1. Single Injection Viscosupplementation
2. Three Injections Viscosupplementation
3. Five Injections Viscosupplementation

Application

1. Knee Osteoarthritis
2. Hip Osteoarthritis
3. Hand/Wrist Osteoarthritis
4. Ankle/Foot Osteoarthritis
5. Others

End User

1. Hospitals
2. Orthopedic clinics/Ambulatory Surgical Centers

Region

1. North America
2. Europe
3. Asia Pacific
4. Rest of World

Key Players

1. Anika Therapeutics Inc.
2. Sanofi
3. Zimmer Biomet
4. Smith & Nephew PLC
5. Lifecore Biomedical
6. LG Life Sciences Ltd.
7. F.Hoffmann-La Roche Ltd.
8. Chugai Pharmaceutical Co.

Key Topics Covered:

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics

5. Global Viscosupplementation Market

6. Market Share – Global Viscosupplementation Analysis

7. Product – Global Viscosupplementation Market

8. Application – Global Viscosupplementation Market

9. End User – Global Viscosupplementation Market

10. Region – Global Viscosupplementation Market

11. Company Analysis

For extra details about this report go to https://www.researchandmarkets.com/r/nx5odw

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s main supply for worldwide market analysis reviews and market information. We give you the most recent information on worldwide and regional markets, key industries, the highest corporations, new merchandise and the most recent tendencies.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outdoors U.S.): +353-1-481-1716